- Report
- October 2024
- 131 Pages
Asia Pacific
From €3489EUR$4,000USD£3,025GBP
- Report
- September 2024
- 88 Pages
India
From €3052EUR$3,500USD£2,647GBP
- Report
- August 2024
- 87 Pages
United States
From €3052EUR$3,500USD£2,647GBP
- Report
- August 2024
- 120 Pages
North America
From €3489EUR$4,000USD£3,025GBP
- Report
- August 2024
- 80 Pages
Japan
From €3052EUR$3,500USD£2,647GBP
- Report
- August 2024
- 82 Pages
Japan
From €3052EUR$3,500USD£2,647GBP
- Report
- July 2024
- 88 Pages
India
From €3052EUR$3,500USD£2,647GBP
- Report
- July 2024
- 82 Pages
India
From €3052EUR$3,500USD£2,647GBP
- Report
- June 2024
- 185 Pages
Global
From €3925EUR$4,500USD£3,404GBP
- Report
- April 2024
- 184 Pages
Global
From €3925EUR$4,500USD£3,404GBP
- Report
- February 2024
- 185 Pages
Global
From €3925EUR$4,500USD£3,404GBP
From €3052EUR$3,500USD£2,647GBP
- Report
- November 2023
- 90 Pages
Germany
From €3052EUR$3,500USD£2,647GBP
- Report
- November 2023
- 149 Pages
Asia Pacific
From €3489EUR$4,000USD£3,025GBP
- Report
- November 2023
- 178 Pages
Global
From €3925EUR$4,500USD£3,404GBP
- Report
- November 2023
- 190 Pages
Global
From €3925EUR$4,500USD£3,404GBP
- Report
- November 2023
- 120 Pages
Europe
From €3489EUR$4,000USD£3,025GBP
- Report
- October 2023
- 126 Pages
North America
From €3489EUR$4,000USD£3,025GBP
- Report
- August 2023
- 78 Pages
Egypt
From €3052EUR$3,500USD£2,647GBP
- Report
- August 2023
- 76 Pages
South Korea
From €3052EUR$3,500USD£2,647GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more